The Influence of Acetamide on Citrate Accumulation after Fluoroacetate Poisoning BY S. GITTER* Departnent of Biochemistry, Univer8ity of Oxford (Received 28 September 1955) Up to 1949 only symptomatic therapy against fluoroacetate poisoning had been attempted, but no satisfactory results could be obtained by several workers. Sedatives and anticonvulsants gave no protection (Foss, 1948) . Bartlett & Barron (1947) and Saunders & Stacey (1948) considered the action of fluoroacetate to be a specific inhibition of acetate metabolism; this led Chenoweth, Scott & Seki (1949) to ascertain whether acetate would protect the animal against fluoroacetate, but little or no protection of the intact rabbit could be obtained by them even after very high doses of sodium acetate. Only by combining acetate with ethanol could Tourtelotte & Coon (1949) obtain protection in mice, and good results were also reported (Hutchens, Wagner, Podolsky & McMahon, 1949) by the use of ethanol alone. Chenoweth, Kandel, Johnson & Bennett (1951) then reported monoacetin as the most efficient protective agent against fluoroacetate poisoning. Gitter, Blank & Bergmann (1953a) showed that acetamide protected white rats against fluoroacetate poisoning when given simultaneously or up to 24 hr. before the dose of fluoroacetate. Acetamide did not protect when given 30 min. or more after the administration of fluoroacetate, even before the convulsions had started.
The protective results obtained suggested that acetamide might belong to those two-carbon sub.
stances, which, according to Peters (1952a) , penetrate into the mitochondria and are consequently able to interfere with the formation of the fluorotricarboxylic acid. The influence of acetamide on the accumulation of citrate after the administration of fluoroacetate has been studied. The effects of monoacetin , propionamide and butyramide on citrate accumulation were also tested. A related problem was the low toxicity which we had observed for fluoroacetamide (Gitter, Blank & Bergmann, 1953 b) , and the effect of this substance on citrate accumulation has also been examined.
EXPERIMENTAL Materials
Acetamide. Acetamide (B.D.H.) was recrystallized and an aqueous solution neutralized by addition of 0-1N-NaOH. The neutralized solution, containing 250mg. of acetamide/ml., was injected subcutaneously to rat in doses of 125 mg./100 g. body wt.
Sodium fluoroacetate. This was prepared in aqueous solutions of 5 and 10 mg./ml.; 0.1 ml./100 g. body wt. was injected intraperitoneally.
Monoacetin. This was given undiluted by subcutaneous or intraperitoneal injection in a dose of 0-5 ml./100 g.
Propionamide and butyramide (a mixture of equal quantities of n-and iso-butyramide). These were injected in a similar manner and dosage as for acetamide (125 mg./ 100 g. body wt.).
White male rats, weighing 120-240 g., and female guinea pigs were used. The animals were killed by decapitation, and extracts of brain, heart and kidney were prepared within 10 min. by grinding the tissues with 8 % trichloroacetic acid in an ice-cold mortar. All experiments with acetamide were performed on animals starved for 16-24 hr. before fluoroacetate treatment.
Citrate was determined in the extracts by the method of Pucher, Sherman & Vickery (1936) as modified by Buffa & Peters (1950) .
RESULTS
Citrate in rat brain, heart and kidney after treatment with acetamide or monoacetin White rats treated only with acetamide showed no toxic signs, though in some cases macroscopic haematuria occurred.
The citrate levels in the organs of these animals were much higher than normal, although they did not reach the level of fluoroacetate-treated animals. Table 1 shows the results obtained 60 and 120 min. after acetamide and monoacetin had been given. Normal values are also shown. These are in agreement with the original findings of Buffa & Peters (1949) , Potter, Busch & Bothwell (1951) and Lindenbaum, White & Schubert (1951) .
With acetamide, maximum citrate values were obtained after 2 hr., and the level then remained approximately constant for several hours. Monoacetin was also found to increase the citrate contents of the organs within 2 hr. to an even greater extent than acetamide, particularly in the heart. Effect of injecting fluoroacetate and acetamide on citrate level8 of ti88ues Accumulation of citrate after administration of fluoroacetate, with and without protection from. acetamide, has been studied. Extracts of brain, heart and kidney of male rats, 35 and 60 min. after injection of sodium fluoroacetate in doses of 5 and 10 mg./kg., were analysed for citrate. Acetamide was always given 2 hr. before sodium fluoroacetate in a single subcutaneous injection. Each time a citrate ratio was calculated, defined as the percentage of the citrate content of an organ of an acetamide-protected animal with respect to the content in the same organ of a non-protected animal, both after fluoroacetate treatment.
The results are shown in Table 2 . In all cases, acetamide was found to have no appreciable effect on citrate accumulation in the brain after fluoroacetate. In the heart, however, which accumulates higher concentrations of citrate than brain, acetamide clearly reduces the citrate ratio. A similar but more pronounced effect is seen in the kidney, where acetamide strongly counteracts the citrate accumulation. Doubling the dose of fluoroacetate or increasing the period of fluoroacetate poisoning from 35 to 60 min. caused the citrate contents of the unprotected animals to rise in heart and kidney but had no effect on the level in brain. Acetamide prevented any further increase of the citrate accumulation in heart and kidney between 35 and 60 min. after a fluoroacetate injection of 5 mg./kg. body weight.
Influence of acetamide on the accumulation of citrate caused by sodium fluoroacetate in guinea pigs It is of importance to know whether or not the effect of acetamide in decreasing citrate accumulation after fluoroacetate is a specific reaction for white rats. Doses of 2 and 4 mg./kg. respectively were therefore injected into eight female guinea pigs, half of which had received acetamide protection. The dose of 2 mg./kg. is well above the LD'10 for these animals. The latent period for guinea pigs is longer than for rats and 75 and 150 min. were therefore allowed to elapse between the administration of fluoroacetate and the preparation of the extract. Results are given in Table 3 . The animals killed after 75 min. had not convulsed, but those killed after 150 min. had all suffered one or more convulsions.
It is seen that the reduced citrate ratio after acetamide injection is found in guinea pigs as well as in rats, especially in kidney. It is not definite in the heart, however, where the values obtained after administration of sodium fluoroacetate (4 mg./kg.) were inconsistent. Brain, however, showed a tendency towards a lower citrate ratio, although again the absolute values for citrate accumulation found in the brain of this species are below those of heart and kidney.
Comnparison of the effects of acetamide and monoacetin
Because of the similarity of the effects produced by acetamide and monoacetin (see Table 1 ), the effects of both compounds on the citrate accumula- tion, provoked by sodium fluoroacetate administered in a dose of 10mg./kg., have been compared. The citrate ratios obtained by administering these substances is given in Table 4 . A similarity is found between the results obtained with each compound; however, monoacetin was also found to reduce the citrate ratio in the brain of white rats.
Effect of fluoroacetamide
This fluoro derivative shows a comparatively low toxicity. A dose of 30 mg./kg. is needed to produce the usual effects of fluoroacetate poisoning with convulsions and ultimate death of the animal. A dose of 10 mg./kg. provoked no visible toxic effects, but 20 mg./kg. appeared to be slightly above the LD50.
From Table 5 it is seen that 20 mg. of fluoroacetamide/kg. produced about the same citrate accumulation as 5 mg. of sodium fluoroacetate/kg. when the animals were protected by acetamide (cf. Table 2 ). Administration of acetamide to fluoroacetamide-treated animals did not result in any appreciable change of the citrate ratio.
As fluoroacetamnide appeared to combine both the toxic action of fluoroacetate and the protective action of acetamide, although the doses of fluoroacetamide were far below those used for acetamide, lower doses of acetamide were tested to determine whether they would also influence the citrate ratio. results are shown in Table 6 . A reduction of citrate in kidney was obtained by this small dose of acetamide, but the effect was less obvious in heart. As before, brain-citrate levels did not respond to either dose of acetamide. These results with low doses of acetamide show that more detailed pharmacological investigations are needed in order to find the minimum effective dose.
Activity of other amides Propionamide, in doses of 125 mg./100 g. body weight, did not have any appreciable influence on citrate accumulation. The citrate ratio for heart was 100, for brain 80, and for kidney 90, 60 min. after administration of sodium fluoroacetate in a dose of 10 mg./kg.
Butyramide, however, in doses of 125 mg./ 100 g. body weight, which alone did not influence the citrate level in brain, lowered the citrate accumulation in heart and kidney, the citrate ratios being 71 and 72% respectively. It is not known whether differences exist between n-and i8o-butyramide, or whether butyramide as such has the protective action, or whether it appears only after conversion into acetamide by fl-oxidation.
Acetamide injected after fluoroacetate
As acetamide might interfere with the formation of fluorocitrate that takes place after the administration of fluoroacetate, the possibility of some protection being obtained by acetamide when given after the administration of fluoroacetate was reinvestigated. Previous negative results, it was argued, could have been due to the fact that the injection of acetamide was delayed at least 30 min. after administration of fluoroacetate; enough fluorocitrate might then have bepn formned in the cells to cause toxic effects. Further, it was known that after 30 min. a powerful inhibition of the tricarboxylic acid cycle had taken place, as indicated by the increased citrate levels in the tissue. However, some definite time must elapse after administration of fluoroacetate before a lethal concentration of fluorocitrate is reached, and acetamide given before the end of this period might still give protection by interfering with the formation of further fluorocitrate. Buffa & Peters, 1949 (1949) and confirmed by subsequent work (Buffa & Peters, 1950; Potter et al. 1951; Peters & Wilson, 1952; Peters, Wakelin, Buffa & Thomas, 1953 ). An active tricarboxylic acid fraction containing fluorine was isolated from poisoned-kidney homogenates (Buffa, Peters & Wakelin, 1951) , and the toxic compound is now thought to be fluorocitric acid (Peters et al. 1953) , which inhibits aconitase (Lotspeich, Peters & Wilson, 1951) , thereby jamming the tricarboxylic acid cycle.
The fact that acetamide and other substances reduce both the toxic effects and the citrate accumulation support the opinion of Peters (1952b) that it is the citrate accumulation which is partly or wholly responsible for the toxic effects of fluoroacetate. and Kandel & Chenoweth (1952) doubted whether high citrate levels were related to the toxic effects of fluoroacetate ministration, as they found that in brain there was complete dissociation of citrate content and toxic symptoms. It may be questioned, however, whether the strange behaviour of brain necessarily indicates a negative conclusion as to the importance of the citrate accumulation. It seems more important to discover why fluoroacetate produces less citrate accumulation in brain and why brain reacts differently from other organs to acetamide. Acetamide protected animals against fluoroacetate poisoning, without, however, being able to prevent the convulsions entirely. As acetamide gives protection when administered before a lethal accumulation of fluorocitrate has occurred as a result of fluoroacetate injection and does not give protection when enough fluorocitrate has been formed in the cell, it appears that acetamide is not capable of counteracting the fluorocitrate, but that it interferes with its formation. Fluorocitrate formation was dependent on the dose of fluoroacetate given, as measured by the citrate-accumulation effect; therefore it is understandable that a very high dose of fluoroacetate will be toxic even in the presence of acetamide, as in spite of the inhibition of fluorocitrate formation by acetamide a lethal concentration can still be reached. Also, acetamide given up to 8 min. after fluoroacetate inhibited further fluorocitrate formation and therefore had a protective action.
Both acetamide and monoacetin influence the reactions of the tricarboxylic acid cycle by causing increased citrate levels in the organs. In this connexion, Mallov & Tepperman (1953) have recently reported that ethanol also caused increased citrate levels in spleen and kidney, and Hutchens et al. (1949) obtained protection against fluoroacetate with ethanol. The low toxicity of fluoroacetamide is also reflected by the increased citrate accumulation that it produces. The ratio of the values of LD50 for sodium fluoroacetate and fluoroacetamide is about 1: 5; this is in accordance with the observation that a dose of 20 mg. of fluoroacetamide/kg. is needed to induce the same citrate accumulation as is caused by 5 mg. of sodium fluoroacetate/kg. The activity of fluoroacetamide may be due to the liberation of fluoroacetate by hydrolysis. It is not surprising that the hydrolysis should be slow in comparison with that of other fluoro compounds which act in the same way by transformation into fluoroacetate (Saunders & Stacey, 1948 , because it is known from the work of Bray, James, Ryman & Thorpe (1948) and Bray, James, Thorpe, Wasdell & Wood (1949) that hydrolysis of acetamide in vitro by organ extracts is very slow.
The lower activity of fluoroacetamide is thus not of the same character as, for example, the nontoxicity of fluoropropionate or fluorosuccinate.
These compounds are inactive, because they cannot participate in any condensation to yield fluorocitrate in which the C-F bond would become part of the fluoroacetyl portion of the fluorocitric acid molecule. SUMMARY 1. The protective effect of acetamide in fluoroacetate poisoning is accompanied in heart and kidney by citrate concentrations that are significantly lower than those found without acetamide. Citrate accumulation in brain is not altered by acetamide.
2. Monoacetin also produces a decreased citrate level in fluoroacetate-treated animals. Both acetamide and monoacetin, however, produce increased citrate concentrations in brain, heart and kidney, when administered without fluoroacetate.
3. Citrate concentrations were proportional to the dose of fluoroacetate and to the period of time after administration of fluoroacetate.
4. Acetamide does not counteract the effect of fluoroacetate poisoning once this has led to a toxic concentration of fluorocitrate in the cells. It does, however, counteract the formation of fluorocitrate and gives protection to white rats when injected before and even up to 8 min. after administration of fluoroacetate.
The author wishes to thank Sir Rudolph Peters In a previous publication (Mills, 1955a) it has been shown that the physiological response of the copper-deficient rat may be used to compare the availability of copper in different dietary supplements. The results of this work indicated that the copper of an aqueous extract of freeze-dried herbage was more readily utilized for haemoglobin formation, melanogenesis, growth and liver-copper storage than an equivalent quantity of copper administered as cupric sulphate. The results of earlier work (Mills, 1954) suggested that much of the copper in herbage exists as organic complexes, but with the methods employed it was not possible to determine the contribution of ionic copper to the total copper content of the soluble components of herbage. The present investigation was designed to determine whether the water-soluble component of herbage which promotes rapid recovery of the copper-deficient rat contains copper mainly as ionic salts or as organic complexes which may or may not be broken down to liberate the free ion in the digestive tract. EXPERIMENTAL Electrodialy8i8 of herbage extrad. A sample (20 g.) of milled, freeze-dried herbage was extracted with 200 ml. of glass-distilled water by stirring for 18 hr. at 37°. The mixture was filtered through muslin and the filtrate centrifuged at 8300g for 1 hr. Before electrodialysis the supernatant was concentrated to Q0 ml. by evaporation in a freeze drier. The apparatus described by Theorell & Akeson (1943) was modified by substituting cellophan and filter-paper membranes for the parchment membranes used by these workers. This modification was necessary to prevent complex-formation between the Cu2+ ions of the dialysate and free amino and carboxyl groups of parchment protein. A further modification was the introduction of a fourth dialysis cell between the cell containing the sample and the catholyte cell (Fig. 1) . Dialysis cells were constructed of * in. Perspex and were connected by i in. diam.
holes in which were placed the membranes interposed between * in. rubber gaskets. Electrodes were of 22 S.W.G. Pt wire wound in I in. diam. spirals. Cooling water was circulated through glass U tubes in each cell and the cell contents were stirred with a stream of N2. Power supplies were from a stabilized power unit of maximum output 100 mA at 250 v. Electrodialysis was carried out for about 9 hr., the current being restricted to 75 mA by a variable rheostat to avoid overheating the cell contents. After this period the current rapidly fell to about 3 mA, indicating that ion transport had virtually ceased. Deter. minations of pH on cell contents were carried out at intervals during electrodialysis. Cell contents were evaporated to dryness before Cu analyss.
Copper analyse8. These were carried out by an adaptation of the method of Eden & Green (1940) . The yellow Cu diethyldithiocarbamate complex was extracted into 2 ml. of amyl alcohol at 200 and the absorption at 432 m,u. was determined by a Beckman spectrophotometer.
Cooling. 
